• FH1 for iPS-Derived Hepatocyte Maturation

  2026-09-17

  FH1 helps turn iPS-derived hepatocyte-like cells into more functional models by improving albumin secretion, CYP3A4 expression, colony morphology, and AFP behavior. This practical guide connects FH1-based maturation workflows with controlled gene-expression assays while emphasizing dose optimization, analytical controls, and translational limitations.

• p-tau Ser356, NUAK1, and Alzheimer’s Pathology

  2026-09-16

  The reference study establishes p-tau Ser356 as a pathology-associated tau species that rises with Alzheimer’s disease progression and is frequently present in neurofibrillary tangles and synaptic compartments. Its brain-slice experiments further show that NUAK inhibition has model-dependent effects, lowering p-tau Ser356 specifically in live human tissue but producing broader tau and neuronal-protein losses in mouse cultures.

• Programmable mRNA for Inflammatory Disc Repair

  2026-09-16

  Inflammatory intervertebral disc degeneration illustrates why mRNA therapeutics increasingly need a cellular delivery strategy. This thought-leadership analysis connects TNF-α biology, LNP-engineered fibroblasts, and disciplined mRNA manufacturing with translational guidance for researchers developing localized regenerative therapies.

• Zolmitriptan: Assay Design Beyond Binding

  2026-09-15

  Zolmitriptan is a selective 5-HT1B receptor agonist for rigorous migraine and cluster headache research. This guide moves beyond target labeling to show how orthogonal assays, solvent controls, and lysosomal-biology insights can improve interpretation without overstating cross-domain evidence.

• (-)-Blebbistatin for Mechanotransduction Studies

  2026-09-15

  Use (-)-Blebbistatin as a reversible, cell-permeable non-muscle myosin II inhibitor to separate actomyosin-generated traction from receptor responses to shear and adhesion. This workflow translates a recent GABAB mechanotransduction finding into practical cytoskeletal dynamics research, cell adhesion and migration studies, and controlled mechanical-stimulation assays.

• Indometacin Sodium: From Mechanism to Translation

  2026-09-14

  Indometacin Sodium Trihydrate offers translational researchers a pathway-aware tool spanning COX biology, prostaglandin synthesis inhibition, pancreatic stellate cell assays, oligodendrocyte differentiation, and reproductive research. This article connects mechanism, assay design, clinical boundaries, and trial-quality thinking beyond the scope of a typical product page.

• TUNEL Apoptosis Detection Kit: Glioma Workflow

  2026-09-14

  Translate DNA fragmentation into clear brown nuclear staining across glioma cultures and tissue sections. This workflow shows how to pair the TUNEL assay with study controls, quantitative imaging, and mechanistic readouts for more defensible programmed cell death research.

• Trichostatin A: A Senescence Assay Strategy

  2026-09-13

  Trichostatin A (TSA) is more than a broad HDAC inhibitor: it can serve as a mechanistic probe for connecting chromatin state, cancer phenotypes, and mitochondrial senescence signaling. This guide translates the TERC-53 findings into a rigorous TSA assay strategy while separating established evidence from testable hypotheses.

• CFDA-SE for Cell Proliferation Tracking

  2026-09-12

  CFDA-SE is a cell-permeable fluorescent reagent for division-resolved labeling of viable cells. Its esterase-activated CFSE product covalently labels intracellular amines, enabling flow cytometry proliferation tracking across immune, stromal, and bacterial models.

• QSHXO Links Autophagy and Ferroptosis in MASLD

  2026-09-11

  Liu et al. report that Qushi Huoxue ointment improves hepatic steatosis and inflammation in a mouse model of metabolic associated steatotic liver disease by coordinating autophagy activation with suppression of ferroptosis-related injury. The study combines histopathology, biochemical testing, serum pharmacochemistry, network pharmacology, molecular assays, and ultrastructural analysis, providing a mechanistic framework for further validation rather than definitive pathway-level proof.

• HMGCS2, LysoPC, and Pulmonary Fibrosis

  2026-09-11

  Yang et al. identify injured type II alveolar epithelial cells as a major source of lipid accumulation in experimental pulmonary fibrosis and connect reduced HMGCS2 activity with LysoPC-mediated fibroblast activation. Their multi-model study positions epithelial lipid catabolism, PPARα signaling, and CPT1A/CPT2 regulation as mechanistic links that may guide future fibrosis research.

• Hypoxia-Primed MSCs Transfer Mitochondria via Gap Junctions

  2026-09-10

  Luo et al. show that hypoxia-preconditioned human bone marrow mesenchymal stem cells improve liver ischemia-reperfusion injury by combining mitochondrial quality control with enhanced gap-junction-mediated mitochondrial transfer. The study identifies Cx43 and Cx32 as functionally important junctional routes and uses pharmacological, biochemical, and genetic approaches to connect connexin activity with graft protection.

• Bay 11-7085: NF-κB Activation Inhibitor Guide

  2026-09-10

  Bay 11-7085 is a practical chemical probe for separating NF-κB-dependent inflammation from cell-cycle arrest and apoptosis. This workflow connects TNFα challenge assays with ER-stress neuroinflammation, endometriosis, and pneumococcal meningitis research while emphasizing controls that prevent overinterpreting cytotoxicity as pathway inhibition.

• JSH-23: Mechanistic Guide to NF-κB Inhibition

  2026-09-09

  JSH-23 is an NF-κB inhibitor designed to separate p65 nuclear transcription from upstream IκB degradation. This guide connects its mechanism to inflammation research, PRV biology, assay design, and translational disease models.

• FH1 (Catalog No. B3700) for iHep Maturation

  2026-09-09

  Learn how FH1 (Catalog No. B3700; SKU B3700) can support more functional iPS cell-derived hepatocyte models through increased albumin secretion, higher CYP3A4 levels, and reduced AFP. This scenario-based guide covers assay interpretation, formulation, storage, workflow controls, and practical supplier selection.

8079 records 1/539 page Next 12345 下5页 Last page